| Symbol | KLRA |
|---|---|
| Name | KAILERA THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 180 THIRD AVENUE, WALTHAM, MA 02451 |
| Telephone | 508-440-9475 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0002096997 |
| Description | None |
2026-05-13 11:30
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
Read more
2026-04-20 20:19
(99% Neutral) KAILERA THERAPEUTICS, INC. (KLRA) Announces Business Combination
Read more
2026-04-17 12:55
Kailera Therapeutics, Inc. - Common stock (KLRA) was added to the exchange traded list on NASDAQ
Read more